Genomatica
San Diego, US · Founded 2000 · Delaware corporation · 218 employees on LinkedIn · 5 known investors
Find your way into Genomatica
756 people in our graph share verified history with the Genomatica team — schools, employers, funds. One of them is your warm intro.
Lyle McCullochunlockedknows Tom McDonald · together at PwC (overlapped)
×4knows the team · via PwC
knows the team · via Massachusetts Institute of Technology
×3knows the team · via UCLA
×2knows the team · via Yale University
knows the team · via Amyris
Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs. It licenses and scales these technologies with industrial partners across the chemicals, beauty, and materials industries in the US, Europe, and Asia.
Founders & leadership
Genomatica was founded in 2000 by Christophe Schilling and Bernhard Palsson.
CS
Christophe SchillinginFounder, Employee #1
BP
Bernhard PalssonCo-founder
CA
Carlos A. CabrerainExecutive Chairman2015–2026
JG
John G. GugelinChief Executive OfficerJohn G. Gugel is CEO of Genomatica, a biotechnology company that develops fermentation-based processes to manufacture bio-based chemicals and materials. He brings extensive experience in technology commercialization, manufacturing, and energy/sustainability sectors, including roles leading strategic transformation at a multinational technology company.
TM
Tom McDonaldinSVP, Finance & Chief Financial OfficerTom McDonald is a CPA with over 20 years of finance experience across startup and commercial-stage companies, including roles in SEC reporting, IPOs, and private financings. He has established financial controls and managed finance teams at companies ranging from early-stage to public.
NB
Nelson BartoninSVP, Research and Development
JL
Jeff LievenseinSenior Engineering Fellow2012–2017Jeff Lievense is Executive Officer at Genomatica, a biotechnology company that develops fermentation-based processes for producing bio-based chemicals and materials. He has worked for decades in industrial biotechnology and process development, with experience across fermentation products, metabolic engineering, manufacturing scale-up, and technology transfer at large corporations, startups, and nonprofits.
MB
Mark BurkinExecutive VP and CTO2006–2017Mark Burk holds a Ph.D. in organic chemistry from Yale University and completed postdoctoral work at MIT; he spent five years in research at DuPont developing the DuPHOS technology, four years as a chemistry professor at Duke University, and six years at Chiroscience Pharmaceuticals before serving as head of R&D at Diversa Corporation, where he led teams in metagenomics and directed evolution technologies. He then spent 12 years at Genomatica as EVP and CTO building the technology platform for engineering microorganisms to produce bio-based chemicals, and has since founded or co-founded multiple biotech companies including Snap Bio and a stealth-mode venture.
MK
Michael KeaneinExecutive Vice President and Chief Financial Officer2011–2016Michael Keane is an executive with over 25 years of experience as CFO and COO across technology, healthcare, telehealth, biotechnology, and manufacturing sectors, including roles at Fortune 150 companies and venture-backed firms; he holds an MBA and CPA.
WH
William H. BaumExecutive
RV
Rasmus von GottbergNamed on SEC filing
CB
Craig BinettiNamed on SEC filing
Investors · 5
Reported raises · per SEC filings
Form D private placements$125.9M disclosed across 2 rounds · 2014–2021
▶$119.1MraisedAug 2021 · 11 investors · Other TechnologyRule 506(b)
▶$119.1MraisedAug 2021 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rasmus von GottbergExecutive Officer
- Thomas McDonaldExecutive Officer
- Christophe SchillingExecutive Officer, Director
- Craig BinettiDirector
- David MuldoonExecutive Officer
- Anders Bendsen SpohrDirector
- Jason KellyDirector
- Eli CasdinDirector
- Carlos A. CabreraExecutive Officer, Director
- Offering amount
- $119.1M
- Amount sold
- $119.1M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.8MraisedMar 2014 · 12 investors · Other TechnologyRule 506(b)
▶$6.8MraisedMar 2014 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christophe SchillingExecutive Officer, Director
- Josh GreenDirector
- Jeff LievenseExecutive Officer
- Warren ClarkDirector
- Just JanszDirector
- Thomas J.G. HuotDirector
- Mark BurkExecutive Officer
- Michael KeaneExecutive Officer
- Geoff DuykDirector
- William H. BaumExecutive Officer, Director
- Leighton ReadDirector
- Offering amount
- $12.4M
- Amount sold
- $6.8M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Genomatica went on to found or lead other companies.
Competitors · 1
by search overlap
Companies competing with Genomatica for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Again acquires Geno to combine AI-driven discovery with industrial biomanufacturing - Tech.eutech.eu · Aug 2026Frequently asked questions
- What does Genomatica do?
- Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs. It licenses and scales these technologies with industrial partners across the chemicals, beauty, and materials industries in the US, Europe, and Asia.
- Who founded Genomatica?
- Genomatica was founded by Christophe Schilling, Bernhard Palsson in 2000.
- Who are Genomatica's investors?
- Genomatica's investors include VantagePoint Capital Partners, Casdin Capital, Draper Fisher Jurvetson (DFJ), Mohr Davidow Ventures, Novo Holdings.
- How much funding has Genomatica raised?
- Genomatica has disclosed $125.9M raised across 2 rounds.
- Where is Genomatica headquartered?
- Genomatica is headquartered in San Diego, US.